Many linkage maps and karyotype analysis have identified extensive collinearity and genomic polymorphisms among Brassica genomes.
Recently, many studies put the sights into genomic polymorphisms in genes involved in drug metabolic pathway and correlated with the target of agents.
GC content shows high heterogeneity along the genome and correlates with many genomic features, such as recombination rate, abundance of single nucleotide polymorphisms (SNPs), and different types of repetitive elements [ 11- 13].
SSR markers have been applied in many genomic research aspects, such as genetic polymorphism detection, genetic relationship determination, genetic map construction and gene localization.
To date, many genomic studies, such as linkage analysis, genome association, genome-wide analysis of single nucleotide polymorphism and copy number variations, have tried to investigate the genetic origin of schizophrenia, without clear-cut results.
The same analysis for the non A-to-G modification levels demonstrates consistency between the individual animals as the modification levels in the GFL and OL tissues form one cluster, and the VL, BG and SG tissues form a second cluster, again suggesting that many of the non A-to-G modifications are due to genomic polymorphisms.
Third, some genomic polymorphisms and somatic mutations are unpredictable from an individual genome without knowledge of the genomic sequence.
In a recent GWA, researchers identified genomic polymorphisms potentially associated with seven different diseases (Wellcome 2007).
IRAP and REMAP markers suggested genomic polymorphisms among Eucalyptus species.
There are many genomic studies on switchgrass.
